Recent advances in radiation therapy for head and neck cancer

ORL

Volumn 69, Issue 1, 2006, Pages 1-12

  Bangalore, Madan ^a   Matthews, Shirnett ^b   Suntharalingam, Mohan ^b,c  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Charged particle; Fractionation; Head and neck cancer; Radiation

Indexed keywords

IRIDIUM 192;

BEAM THERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHONDROSARCOMA; CHORDOMA; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; GAMMA KNIFE RADIOSURGERY; GLOSSECTOMY; HEAD AND NECK CANCER; HUMAN; IMAGE QUALITY; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; MOUTH CANCER; NASOPHARYNX CANCER; NEUTRON THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; RADIOSENSITIVITY; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; STEREOTAXIC SURGERY; SURVIVAL RATE; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TUMOR LOCALIZATION; TUMOR VOLUME; XEROSTOMIA;

BRACHYTHERAPY; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; RADIOSURGERY; RADIOTHERAPY, CONFORMAL;

EID: 33845777984     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096710     Document Type: Review

References (74)

1. American Cancer Society, Inc: Surveillance Research, report, 2004.
2. Emmanuella Joseph M, Laurence Baibak M: Head and neck cancer: squamous cell carcinoma. emedicine·4-26-2004.
3. Shaha AR, Strong EW: Cancer of the head and neck; in: American Cancer Society Textbook of Clinical Oncology, Atlanta, 1995, pp 355-377.
4. Watling DL, Gown AM, Coltrera MD: Overexpression of p53 in head and neck cancer. Head Neck 1992;14:437-444.
5. Radiation: CANCERQUEST. 5-1-2003.
6. Weller SA, Goffinet DR, Goode RL, Bagshaw MA: Carcinoma of the oropharynx. Results of megavoltage radiation therapy in 305 patients. Am J Roentgenol 1976;126:236-247.
7. Mendenhall WM, Parsons JT, Cassisi NJ, Million RR: Squamous cell carcinoma of the tonsillar area treated with radical irradiation. Radiother Oncol 1987;10:23-30.
8. Fu KK, Clery M, Ang KK, Byhardt RW, Maor MH, Beitler JJ: Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int J Radiat Oncol Biol Phys 1995;32:589-597.
9. Horiot JC, Bontemps P, van den BW, Le Fur R, van den WD, Bolla M, et al: Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111-121.
10. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
11. Wang CC: Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx: techniques and results. Cancer 1989;63:2461-2467.
12. Ang KK: Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 1998;8:230-236.
13. Marcial VA, Pajak TF, Chang C, Tupchong L, Stetz J: Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 1987;13:41-47.
14. Cox JD, Pajak TF, Marcial VA, Hanks GE, Mohiuddin M, Fu KK, et al: Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13. Int J Radiat Oncol Biol Phys 1990;18:515-521.
15. Parsons JT, Mendenhall WM, Cassisi NJ, Isaacs JH, Jr., Million RR: Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys 1988;14:649-658.
16. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M: A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-136.
17. Wang CC, Blitzer PH, Suit HD: Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985;55(9 suppl):2100-2104.
18. Ang KK, Peters LJ, Weber RS, Maor MH, Morrison WH, Wendt CD, et al: Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990;19:1339-1345.
19. Allal AS, Bieri S, Miralbell R, Marchal F, Lehmann W, Kurtz JM: Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomas. Int J Radiat Oncol Biol Phys 1997;38:685-689.
20. Ang KK: Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 1998;8:230-236.
21. Lichter AS: Three-dimensional conformal radiation therapy: a testable hypothesis. Int J Radiat Oncol Biol Phys 1991;21:853-855.
22. Thames HD Jr, Peters LJ, Spanos W Jr, Fletcher GF: Dose response of squamous cell carcinomas of the upper respiratory and digestive tracts. Br J Cancer Suppl 1980;41(suppl 4):35-38.
23. Bleehen NM, Stenning SP: A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma: the Medical Research Council Brain Tumour Working Party. Br J Cancer 1991;64:769-774.
24. Denham JW: The radiation dose-response relationship for control of primary breast cancer. Radiother Oncol 1986;7:107-123.
25. Thames HD, Schultheiss TE, Hendry JH, Tucker SL, Dubray BM, Brock WA: Can modest escalations of dose be detected as increased tumor control? Int J Radiat Oncol Biol Phys 1992;22:241-246.
26. Suit HD: Local control and patient survival. Int J Radiat Oncol Biol Phys 1992;23:653-660.
27. 125I implantation. Int J Radiat Oncol Biol Phys 1991;21:537-547.
28. Leibel SA, Ling CC, Kutcher GJ, Mohan R, Cordon-Cordo C, Fuks Z: The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys 1991;21:805-811.
29. Leibel SA, Scott CB, Mohiuddin M, Marcial VA, Coia LR, Davis LW et al: The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991;21:549-556.
30. Emami B, Purdy JA, Simpson JR, Harms W, Gerber R, Wippold JF: 3-D conformal radiotherapy in head and neck cancer. The Washington University experience. Front Radiat Ther Oncol 1996;29:207-220.
31. Guerrero Urbano NC: Clinical use of intensity-modulated radiotherapy. Part I. Br J Radiol 2004;77:88-96.
32. Chao KS, Low DA, Perez CA, Purdy JA: Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int J Cancer 2000;90:92-103.
33. Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, et al: Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001;61:275-280.
34. Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA et al: A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-916.
35. Choa CK OG: Intensity-Modulated Radiation Therapy for Head and Neck Cancer. Philadelphia, Lippincott Williams & Wilkins, 2002, 2004.
36. Cheng JC, Chao KS, Low D: Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 2001;96:126-131.
37. Butler EB, Teh BS, Grant WH, III, Uhl BM, Kuppersmith RB, Chiu JK et al: Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:21-32.
38. Clark C, Bidmead M, Mubata CD, Harrington CD, Nutting CM: Intensity modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol. In press.
39. Claus F, Boterberg T, Ost P, De Neve W: Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT: can we avoid dry eye syndrome? Radiother Oncol 2002;64:205-208.
40. Postoperative intensity-modulated radiation therapy for head and neck cancer. 3 A.D. Apr 26;2003.
41. Eisbruch A, Ship JA, Dawson LA, Kim HM, Bradford CR, Terrell JE et al: Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 2003;27:832-837.
42. Ship JA, Eisbruch A, D'Hondt E, Jones RE: Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results. J Dent Res 1997;76:807-813.
43. D'Hondt E, Eisbruch A, Ship JA: The influence of pre-radiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers. Spec Care Dentist 1998;18:102-108.
44. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C et al: Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22.
45. Hunt MA, Zelefsky MJ, Wolden S, Chui CS, LoSasso T, Rosenzweig K et al: Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49:623-632.
46. De Neve W, De Gersem W, Derycke S, De Meerleer G, Moerman M, Bate MT et al: Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol 1999;50:301-314.
47. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R: The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46:195-205.
48. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R: Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000;46:619-630.
49. Miles EA, Clark CH, Guerro Urbano MT, Dearnaley DP, Nutting CM: How routine can IMRT become in daily clinical practice? Clin Oncol 2003;15,S30:40.
50. Withers HR: Inherent acceleration of tumor dose-rate in hyperfractionated regimens. Int J Radiat Oncol Biol Phys 1988;14:400.
51. Cozzi L, Fogliata A: IMRT in the treatment of head and neck cancer: is the present already the future? Expert Rev Anticancer Ther 2002;2:297-308.
52. Penagaricano JA, Papanikolaou N: Intensity-modulated radiotherapy for carcinoma of the head and neck. Curr Oncol Rep 2003;5:131-139.
53. Le QT, Tate D, Koong A, Gibbs IC, Chang SD, Adler JR, et al: Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003;56:1046-1054.
54. Lee N, Millender LE, Larson DA, Wara WM, McDermott MW, Kaplan MJ, et al: Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull. Head Neck 2003;25:210-216.
55. Miller RC, Foote RL, Coffey RJ, Gorman DA, Earle JD, Schomberg PJ, et al: The role of stereotactic radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys 1997;39:977-981.
56. Ahn YC, Lee KC, Kim DY, Huh SJ, Yeo IH, Lim DH, et al: Fractionated stereotactic radiation therapy for extracranial head and neck tumors. Int J Radiat Oncol Biol Phys 2000;48:501-505.
57. Baumert BG, Norton IA, Davis JB: Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base. Int J Radiat Oncol Biol Phys 2003;57:580-592.
58. Hirohiko T, Tatsuya O: Cancer Heading for a Heavy Fall. LOOK Japan, 2003.
59. Brown AP, Urie MM, Chisin R, Suit HD: Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning. Int J Radiat Oncol Biol Phys 1989;16:1607-1614.
60. Lin R, Slater JD, Yonemoto LT, Grove RI, Teichman SL, Watt DK, et al: Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy: dose-volume histogram analysis. Radiology 1999;213:489-494.
61. Munzenrider JE, Liebsch NJ: Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(suppl 2):57-63.
62. Munzenrider J, Liebsch N, Efrid J: Chordomas and chondrosarcomas of the skull base: treatment with fractionated x-ray and proton radiotherapy; in Johnson JT, Didolkar M (eds): Head and Neck Cancer. Proceedings of the Third International Conference on Head and Neck Cancer. International Congress Series, No. 1009. Amsterdam, Excerpta Medica, 1993, Vol 3, pp 649-654.
63. Tokuuye K, Akine Y, et al: Proton therapy for head and neck malignancies at Tsukuba. Strahlenther Onkol 2004;180:96-101.
64. Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C, et al: Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull bas: results in 67 patients. Strahlenther Onkol 2003;179:598-605.
65. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE: Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 2003;129:944-948.
66. Douglas JG, Einck J, Austin-Seymour M, Koh WJ, Laramore GE: Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands. Head Neck 2001;23:1037-1042.
67. Mazeron JJ, Noel G, Simon JM: Head and neck brachytherapy. Semin Radiat Oncol 2002;12:95-108.
68. Quon H, Harrison LB: Brachytherapy in the treatment of head and neck cancer. Oncology (Huntingt) 2002;16:1379-1393.
69. Lau HY, Hay JH, Flores AD, Threlfall WJ: Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996;39:15-18.
70. Friedrich RE, Krull A, Schwarz R, Thurmann H, Plambeck K, Schmelzle R: Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx: results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery. Strahlenther Onkol 1997;173:507-512.
71. Kakimoto N, Inoue T, Inoue T, Murakami S, Furukawa S, Yoshida K, et al: Results of low-and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol 2003;68:123-128.
72. Harrison LB, Lee HJ, Pfister DG, Kraus DH, White C, Raben A, et al: Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head Neck 1998;20:668-673.
73. Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, Kraus DH, et al: Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997;19:169-175.
74. Strnad V, Geiger M, Lotter M, Sauer R: The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Brachytherapy 2003;2:158-163.